Accord Healthcare
Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
Falsified Medicines Directive
The Falsified Medicines Directive, or FMD, is a set of legislation passed by the European Union Parliament, it is designed to protect patients by addressing the issue of falsified medicines entering the legitimate medicines supply chain within Europe.
Click Here
GROWTH’S IN OUR NATURE
Accord Healthcare is one of the fastest growing generic pharmaceutical companies in the UK & Ireland.
Acquiring Actavis UK and Ireland in 2017 facilitates Accord’s ambition to become a top 5 pan-EMENA generics company by 2021 and have developed a specialty products commercialisation capability.
TRULY MULTINATIONAL
Accord has one of the most extensive sales, marketing and distribution networks in Europe. Headquartered from UK, Accord now supplies products to close to 65 EMENA markets.
A COMPLETE APPROACH
Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.
EUROPEAN FOCUS
Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.
News
Accord UK’s Managing Director shares perspective on Oxera Report’s study into the UK generic medicines market
Pharmacists are a crucial player in maintaining an effective generics medicine market in the UK.
Pete Kelly, Managing Director gives Accord's view to Pharmacy Business on Oxera's...
Oxera study
Oxera study concludes UK generic medicines market functioning well. Read more here: www.britishgenerics.co.uk*
*You are now leaving an Accord site